CUIDADOS QUE O CIRURGIÃO-DENTISTA DEVE TOMAR NO MOMENTO DE TRATAR CIRURGICAMENTE UM PACIENTE EM USO DE ANTICOAGULANTES OU ANTIAGREGANTES PLAQUETÁRIOS

Anticoagulants and antiplatelet agents are drugs used by a large portion of the world population. They are used to prevent at-risk patients from developing cardiovascular diseases, such as acute myocardial infarction (AMI) or stroke (stroke). Because they are widely used, the dental surgeon may constantly encounter patients using anticoagulants or anti-aggregating agents in their clinical routine. In this case, the professional will need to be aware of the most current management standards with each type of medication, so that the treatment is carried out successfully. In the present work, a Standard Operational Protocol (POP) is proposed, which can be followed when performing oral surgeries on patients using Warfarin, Acetyl Salicylic Acid, Low Molecular Weight Heparin, Unfractionated Heparin, Rivaroxaban and Clopidogrel. Keywords: Warfarin; Acetylsalicylic acid; Low Molecular Weight Heparin; Unfractionated Heparin; Clopidogrel; Anticoagulant.